51. Scleroderma Clinical trials / Disease details
Clinical trials : 525 / Drugs : 565 - (DrugBank : 148) / Drug target genes : 114 - Drug target pathways : 217
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT05251415 (ClinicalTrials.gov) | April 4, 2022 | 24/1/2022 | Clinico-biological Collection to Investigate the Physiopathology of Systemic Autoimmune Diseases | Constitution of a Collection of Biological Samples With the Aim of Carrying Out Clinico-biological and Pathophysiological Investigations of Systemic Autoimmune Diseases | Lupus Erythematosus;Scleroderma;Myositis;Vasculitis;Inflammatory Bowel Diseases | Biological: Blood sampling | University Hospital, Toulouse | NULL | Recruiting | 6 Years | 99 Years | All | 3000 | France |